News I Sino Bioengineering

In commercial-scale biopharmaceutical manufacturing, bioreactor occupancy directly determines annual output capacity, equipment utilization rate and project return on investment. L……

During mammalian cell fed-batch and perfusion cultivation for monoclonal antibodies, viral vectors and recombinant proteins, cells enter the peak exponential growth phase with expl……

As biopharmaceutical manufacturers shift from pilot-scale trials to large-volume commercial production, 1000 L and larger stirred-tank bioreactors have become standard core equipmen……

High-density fed-batch and perfusion mammalian cell cultures have become mainstream upstream manufacturing strategies for monoclonal antibodies, recombinant proteins, viral vectors……

Engineered for full-scale commercial biomanufacturing, this industrial-grade bioreactor serves as the core upstream production equipment for large-volume manufacturing of monoclonal……

Biopharmaceutical downstream processing has long been constrained by the bulky infrastructure, excessive resin consumption, and large facility footprint inherent to traditional batch……

Primary clarification constitutes a foundational unit operation in biomanufacturing, directly determining downstream process efficiency, product purity, and overall production econom……

Biopharmaceutical manufacturing is undergoing a profound paradigm shift from conventional batch-oriented production to intensified continuous manufacturing workflows. As the core bot……

Synthetic biomanufacturing has emerged as a sustainable alternative to traditional chemical synthesis, enabling the microbial production of high-value chemicals, pharmaceuticals, bio……

Mammalian cell culture serves as the core technological foundation for the industrial production of monoclonal antibodies, recombinant proteins, viral vectors, and other high-value b……

Oxygen mass transfer is a core limiting factor dictating the efficiency and yield of microbial fermentation and mammalian cell culture processes in large-scale stainless steel stirre……

Traditional fed-batch bioreactor systems have long served as the mainstream upstream manufacturing platform for biopharmaceuticals, industrial enzymes, and microbial bioproducts due ……

Fermentation scale-up from laboratory bench to industrial bioreactors is a critical step in biomanufacturing for pharmaceuticals, biofuels, and biochemical production. However, exces……

Batch variance remains one of the most persistent and costly challenges in biomanufacturing, directly impacting product yield, purity, consistency, and regulatory compliance. Subtle ……

In the rapidly evolving landscape of biopharmaceutical manufacturing, upstream cell culture productivity has become the core bottleneck restricting the industrialization of monoclona……

Bioreactor scale-up is the core link from laboratory scale cultivation to industrial production in biopharmaceuticals, microbial fermentation, and cell therapy manufacturing. However……